Healthy Clinical Trial
Official title:
fMRI and Spectroscopy Studies of Cortical Plasticity at 1.5 and 3 Tesla
This study will use magnetic resonance imaging (MRI) scans to explore how the brain changes
(reorganizes itself) in response to learning and to brain lesions in healthy people and
people with various physical disabilities.
Normal volunteers and patients with disabilities including blindness, limb amputation,
hemispherectomy (removal of a cerebral hemisphere), and stroke may be eligible for this
study. Candidates will be screened with medical and neurological examinations.
Participants will have MRI scans while they lie still or perform certain movements, as
instructed. MRI uses a strong magnetic field and radio waves instead of X-rays to show
structural and chemical changes in tissues. During the scan, the subject lies on a table in
a narrow cylinder containing a magnetic field. He or she can speak with a staff member
through an intercom system at all times during the procedure. All participants will first
have a scan to show brain structure, which will take about 30 minutes. A second scan will
measure blood flow or biochemical concentration and will take from 1 to 2 1/2 hours.
Depending on their disability, patients will participate in one of the following tests:
- Blindness-This will study the ability of blind people to process tactile information.
- Stroke- This will study mechanisms underlying recovery of motor function after stroke.
The patient will perform voluntary movements or remain still during the scan.
- Amputation- This will study mechanisms underlying the ability of the brain to
reorganize after amputation. The patient will move different parts of the body or
remain still during the scan.
- Hemispherectomy- This will study mechanisms underlying the ability of one side of the
brain to control movements of both arms. The patient will make different kinds of
movements during the scan.
Normal volunteers will participate in one of the following tests:
- Use-dependent plasticity- This will evaluate the effectiveness of amphetamine and
placebo in demonstrating brain flexibility. The volunteer will take an amphetamine or
placebo (inactive pill) before the scan and then perform a specific exercise using the
thumb.
- Motor fatigue- This will study the mechanisms that underlie fatigue, which affect many
patients with neurological conditions. The volunteer will contract muscles in the
forearm and hand for several minutes until he or she feels fatigue.
- Light deprivation- This will evaluate changes in the brain that occur after light
deprivation. The volunteer will remain at rest in the scanner for up to 150 minutes.
- Somatosensory stimulation-This will examine whether stimulation of the wrist can cause
changes in hand representation in the part of the brain that controls movement. The
volunteer will make hand movements at different times during the test. In addition,
mild electric shocks will be delivered to the wrist for up to 2 hours. Although the
shock intensity is regulated to avoid pain, there may be some discomfort.
The purpose of this protocol is to investigate plastic changes in human cerebral cortex in health and disease. The overall hypothesis is that it is possible to identify neuroimaging patterns reflecting reorganization in the human cerebral cortex using fMRI and that it is possible to obtain information on the mechanisms underlying some of these plastic changes by using magnetic resonance spectroscopy (MRS) of GABA. This information is potentially important for the understanding of mechanisms of cortical reorganization operating in humans. Patients and normal volunteers will be scanned at rest and during performance of different tasks. These studies should provide new information on mechanisms of human plasticity. The MRI techniques used for that purpose are functional MRI (fMRI), MR spectroscopy (MRS), and conventional MRI with magnets between 1.5 and 4 tesla. ;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |